NCT00159380View on ClinicalTrials.gov

Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions

Asthma

Interventions

DRUG

Aminoguanidine

500mg

DRUG

Placebos

2ml

Trial Locations (1)

SW3 6LY

Section of Airway Disease, Asthma Lab, Imperial College London, Royal Brompton Hospital, London

All Listed Sponsors

lead

Imperial College London

OTHER

NCT00159380 - Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects | Biotech Hunter | Biotech Hunter